EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Thrombotic and bleeding complications in patients with AL amyloidosis

Despina Fotiou iD, Foteini Theodorakakou iD, Sotiria Spiliopoulou, Maria Gavriatopoulou iD, Magdalini Migkou iD, Nikolaos Kanellias, Evangelos Eleutherakis-Papaiakovou, Panagiotis Malandrakis, Ioanna Dialoupi, Maria Roussou, Ioannis Ntanasis-Stathopoulos iD, Evangelos Terpos iD und 2 weitere

British Journal of Haematology · 2024-05 · 204 (5) · 1816-1824

DOI: 10.1111/bjh.19331 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Haematology, online erschienen am 06.02.2024. Verfasst von Despina Fotiou und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece. Hauptthemen laut MEDLINE: Hemorrhage, Immunoglobulin Light-chain Amyloidosis. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Haemostatic abnormalities and deregulated coagulation are common complications in AL amyloidosis. The relevant risks of thromboembolic and haemorrhagic events have not been thoroughly evaluated. To describe clinically significant thrombotic/haemorrhagic events in 450 consecutive patients with AL amyloidosis. Venous thromboembolic events (VTEs) were reported in 6% and arterial embolic events (AEEs) in 5% of patients, respectively, during a 55‐month median follow‐up. Lower albumin, lower eGFR, higher BM infiltration, soft tissue involvement, IMiD‐based therapy and prior thrombosis were associated with VTE risk. Prior thrombosis was the only independent prognostic variable (HR 9.3, p = 0.001). Coronary arterial disease, prior AEE, 24‐h proteinuria and higher platelet counts were associated with AEE risk. Significant bleeding events were reported in 9%, and associated mortality was 19%. Liver involvement, higher serum creatinine and higher baseline VWF:Ag levels were linked to bleeding risk. Using competing risk analysis, the cumulative probability of thrombosis/bleeding was higher during the first year following diagnosis, but a stable lower risk for both events remained for the duration of follow‐up. In AL amyloidosis patients, the risk of thrombotic/arterial embolic events is significant, but the bleeding risk is also high. A multiparametric assessment is required to initiate anti‐thrombotic or anti‐platelet therapy appropriately.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HemorrhageImmunoglobulin Light-chain AmyloidosisHumansMaleFemaleMiddle AgedAgedThrombosisRisk FactorsFollow-Up StudiesAmyloidosisAdultAged, 80 and over

Stichwörter der Autor:innen

AL amyloidosisarterial embolic eventsbleeding riskvenous thromboembolism

Autor:innen und Institutionen

  • Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece.

ORCID-Profile: Despina Fotiou, Foteini Theodorakakou, Maria Gavriatopoulou, Magdalini Migkou, Ioannis Ntanasis-Stathopoulos, Evangelos Terpos, Meletios A Dimopoulos, Efstathios Kastritis

Zitieren

APA

Fotiou, D., Theodorakakou, F., Spiliopoulou, S., Gavriatopoulou, M., Migkou, M., Kanellias, N., Eleutherakis-Papaiakovou, E., Malandrakis, P., Dialoupi, I., Roussou, M., Ntanasis-Stathopoulos, I., Terpos, E., Dimopoulos, M. A., & Kastritis, E. (2024). Thrombotic and bleeding complications in patients with AL amyloidosis. British Journal of Haematology, 204(5), 1816-1824. https://doi.org/10.1111/bjh.19331

Vancouver

Fotiou D, Theodorakakou F, Spiliopoulou S, Gavriatopoulou M, Migkou M, Kanellias N, et al. Thrombotic and bleeding complications in patients with AL amyloidosis. British Journal of Haematology. 2024;204(5):1816-1824. doi:10.1111/bjh.19331

BibTeX
@article{Fotiou2024,
  author = {Fotiou, Despina and Theodorakakou, Foteini and Spiliopoulou, Sotiria and Gavriatopoulou, Maria and Migkou, Magdalini and Kanellias, Nikolaos and Eleutherakis-Papaiakovou, Evangelos and Malandrakis, Panagiotis and Dialoupi, Ioanna and Roussou, Maria and Ntanasis-Stathopoulos, Ioannis and Terpos, Evangelos and Dimopoulos, Meletios A and Kastritis, Efstathios},
  title = {Thrombotic and bleeding complications in patients with AL amyloidosis},
  journal = {British Journal of Haematology},
  year = {2024},
  volume = {204},
  number = {5},
  pages = {1816--1824},
  doi = {10.1111/bjh.19331}
}
Kostenlos starten →